QuickView for CHRM5;jsessionid=92BB3F68556BF22B30BF4D2FDC885E82 (gene)

1. Recessive CHRM5 variant as a potential cause of neurogenic bladder.
2. Allosteric modulation of a chemogenetically modified G protein-coupled receptor.
3. Muscarinic receptor trafficking.
4. Activation and dynamic network of the M2 muscarinic receptor.
5. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

There were no clinical trials for CHRM5;jsessionid=92BB3F68556BF22B30BF4D2FDC885E82